POTEE Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83409
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human POTEE. Peptide sequence: NGATAGNGDDGLIPPRKSRTPESQQFPDTENEEYHSDEQNDTQKQFCEEQ The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for POTEE Antibody
![Western Blot: POTEE Antibody [NBP2-83409]](https://resources.bio-techne.com/images/products/POTEE-Antibody-Western-Blot-NBP2-83409-img0001.jpg "Western Blot: POTEE Antibody [NBP2-83409]")
Western Blot: POTEE Antibody [NBP2-83409]
Western Blot: POTEE Antibody [NBP2-83409] - Host: Rabbit. Target Name: POTEE. Sample Tissue: Human THP-1 Whole Cell lysates. Antibody Dilution: 1ug/mlApplications for POTEE Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: POTEE
Alternate Names
A26C1, A26C1A, ANKRD26-Like Family C Member 1A, ANKRD26-Like Family C, Member 1A, Cancer/Testis Antigen Family 104, Member 2, CT104.2, POTE Ankyrin Domain Family Member E, POTE2, POTE-2, POTE2gamma, Prostate, Ovary, Testis-Expressed Protein On Chromosome 2, Protein Expressed In Prostate, Ovary, Testis, And Placenta 2
Gene Symbol
POTEe
Additional POTEE Products
Product Specific Notices for POTEE Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...